State Ledger
Company profile

Genprex, Inc. CIK 1595248

Ticker
GNPX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Austin, TX 78746
Fiscal year end
2025 (FY)
Market Data
Close
$2.58
Change
-$0.12
Change %
-4.44%
Volume
771

GNPX · trading date Oct 13, 2026 · previous close $2.70 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$16.23M
Total assets
$10.16M
Total liabilities
$2.20M
Stockholders' equity
$7.96M
Cash & equivalents
$7.83M
Operating income
-$15.52M
Operating cash flow
-$15.31M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
21.6%
Equity / assets
78.4%
CapEx / revenue
—
Operating cash flow / net income
0.94×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$16.23M $10.16M $2.20M $7.96M
2024 $0 -$21.11M $4.12M $2.50M $1.62M
2023 $0 -$30.86M $10.67M — $7.42M
2022 $0 -$23.74M $25.09M — $22.27M
2021 $0 -$20.66M $42.86M $1.59M $41.28M
Company Details
SIC code
2834
State of incorporation
TX
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-18
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Austin, TX 78746
3300 BEE CAVE ROAD SUITE 650-227
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies